eMI Aesthetics review
eMI combines doctor-guided weight management with AI body visualization. Its medication cards and program descriptions do not establish one complete price and payment interval for every offered preparation.
eMI Aesthetics review: clinical GLP-1 pathways, injection and oral options, starting-price limitations, premium follow-up and the distinction between simulation and treatment.
Our verdict
eMI is worth comparing if visual progress tools help you stay engaged and you also want a distinct clinical prescribing relationship. Treat those as separate parts of the service. An AI preview can support a conversation about goals, but it is not a forecast that a particular medicine will produce that appearance. The public offer also needs a more precise payment agreement before it becomes a useful cost comparison. Obtain the named preparation, supplied period and total before selecting a longer pathway or relying on a generic starting figure.
Disclosure: GLP Loss is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
At a glance
- Category
- GLP-1 telehealth
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection · Oral
- States
- 50
- Prescription
- Required
- Updated
- October 2026
What it is
The current site presents eMI as both an AI aesthetics platform and a route to doctor-guided weight-management care. Its clinical telehealth consent identifies eMI Aesthetics as a brand of EntityMed Inc. The site links the prescribing intake to OpenLoop Health, while its separate simulator services involve different tools and interfaces. Confirm which organization handles clinical questions, records and billing for the selected program rather than assuming every eMI page describes the same service agreement.
How it works
The GLP-1 pathway page describes an online intake, medical review, a personalized plan if appropriate, delivery and continuing support. The premium page separately advertises biweekly provider visits and personalized progress tracking. Ask whether that visit frequency belongs to the offer you are selecting and how appointments are arranged. A premium feature should not be transferred automatically to every lower-dose or shorter pathway. Find out who responds between appointments and what happens if a provider recommends an in-person assessment.
Pricing transparency
Current medication cards show starting amounts of $119 for semaglutide, $102 for tirzepatide and $146 for oral semaglutide. The shared FAQ still gives a generic starting figure of $179 per month. Those statements do not attach a complete supplied period and inclusion list to each named quote. Ask for the actual upfront total, renewal interval and preparation before comparing them as monthly drug prices. The public pathway lengths are program descriptions; they should not be used alone to invent a recurring billing schedule or divided all-in amount.
Branded vs compounded
The program page lists semaglutide and tirzepatide injections plus oral semaglutide, with separate lower-dose pathways. Its medication page also names branded Zepbound and Ozempic injections. Obtain the actual branded or compounded preparation for the selected prescription rather than treating the generic ingredient name as that answer. Compounded drugs lack FDA approval and premarket FDA verification of safety, effectiveness or quality. The telehealth consent specifically includes a section for compounded prescriptions. Keep the formulation, concentration and directions tied to your actual order, and contact the prescriber before making a change.
Pros and watch-outs
What we like
- The clinical program and visual tools can be assessed as distinct services.
- The premium page describes a specific provider-visit cadence.
- Published cancellation terms identify a notice deadline before the next charge.
Watch-outs
- Starting-price cards do not establish a complete term-specific prescription total.
- A preview image does not establish an individual treatment outcome.
- Generic program language does not identify the assigned clinician, dispenser or exact preparation for every offer.
Sources
- Current platform and clinical intake links
- GLP-1 pathway lengths and workflow
- Premium visit and tracking description
- Current medication cards and expanded clinical FAQ
- AI body-simulation workflow
- Clinical telehealth and compounded-treatment consent
- Subscription cancellation and refund policy
- Clinical service terms of use
- FDA explanation of compounded drug approval status
Best for
Someone interested in visualization alongside clinical care who can verify the chosen program and payment agreement before enrolling.
Who should look elsewhere
Someone expecting the simulator to predict a medical result or treating any starting quote as a universally available all-in prescription price.
How eMI Aesthetics compares
A few alternatives worth a look, depending on what you’re optimizing for.
- SkinnyRx
A tirzepatide price you can check
See SkinnyRx → - Shed
Compounded pricing without a membership
See Shed → - RxSpan MD
Comparing plan terms upfront
See RxSpan MD →
More GLP-1 telehealth sellers reviews: Nex Gen Health RxNexLifeNext VialNextMedsNiceRxNirwana Health
Pricing & provider data · Last updated October 2026
How we assessed this. This review reflects GLP Loss’s own read of eMI Aesthetics’s publicly-stated model — pricing transparency, clinical oversight, medication clarity, and access — against our editorial methodology. We publish no fabricated ratings or first-hand outcomes. A partnership never changes the assessment — see how we make money.
Frequently asked
- What program lengths does eMI describe?
- The main weight-loss pathway lists four-, twelve-, twenty-four- and fifty-two-week options. The lower-dose pathway lists four and twelve weeks. These describe the offered paths, not proof that the card is charged on those same intervals. Ask for the actual payment dates, supplied quantity and change-of-treatment terms for the selected plan.
- Does a simulation require me to start medication?
- The medication FAQ says the simulator can be used without taking a GLP-1. Its separate simulator page describes uploading a body photo and entering measurements to generate a visual model. Decide whether that tool is useful on its own rather than treating access to an image preview as clinical eligibility or a prescribing decision.
- What should I make of the illustrated before-and-after result?
- It is a generated visualization, not a measured outcome for you. Keep actual progress records and discuss realistic goals with the clinician. Consider whether uploading a body photograph is comfortable for you, and read the simulator’s privacy agreement separately from the clinical consent before deciding which tools to use.
- Is the medication offer branded or compounded?
- The medication page names certain brands as well as generic ingredient-based options, and the clinical consent addresses compounded prescriptions. Ask which exact product is proposed and how its label and preparation differ from alternatives. Do not assume a starting generic quote buys one of the separately listed branded pens.
- What notice is required to stop the subscription?
- The cancellation policy requires a request at least seventy-two hours before the billing date. Missing that deadline can leave the next charge in place, with cancellation applying to the subsequent cycle. Submit the request early enough to retain confirmation. Canceling future access does not by itself establish a refund for an existing purchase.
- What happens if the provider disqualifies me?
- The policy initially promises a full refund for medical disqualification, then describes refunding the remaining subscription charges after a later disqualification. It otherwise excludes ordinary cancellation refunds and limits approved refunds to the most recent cycle. Ask which rule applies to an initial rejection versus a change in eligibility after care has begun.
- Is care available in every state?
- The current medication FAQ says eligible patients can access the program in all fifty US states through its provider network, subject to regulations and clinical eligibility. That is the seller’s coverage statement, not independent license verification or a guarantee that every preparation can be prescribed in every location. Confirm the exact offer for your state.
- How are a damaged order and a change of treatment handled?
- The cancellation policy says damaged medication may be replaced after evidence is supplied and incorrect medication will be replaced by the pharmacy. Ask for the assigned dispenser and contact instructions before delivery. If the prescription changes for clinical reasons, establish the replacement and payment arrangement before assuming the earlier purchase can simply be exchanged.